Posted November 27, 2013
Drug company Novartis stands to gain from Princeton meningitis outbreak. The FDA and the Centers for Disease Control and Prevention (CDC) have approved the importation of Novartis’s menengitis vaccine Bexsero into the US despite it not being FDA-approved. They are doing this even though the Princeton outbreak is not an epidemic, as only seven students have been infected, everyone has recovered, and the disease is not expected to spread off-campus. Read more and TAKE ACTION to tell the FDA and CDC to ask that the Institute of Medicine study all vaccine AERs!.